MLchartDataset catalogue

Lynparza

Term · Oncology and biomedicine · MLC-T-ONC-005057

A drug used alone or with other drugs to treat adults with certain types of prostate cancer, pancreatic cancer, breast cancer, or ovarian, fallopian tube, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. Lynparza blocks an enzyme involved in many cell functions, including the repair of DNA damage. Blocking this enzyme may help keep cancer cells from repairing their damaged DNA, causing them to die. Lynparza is a type of PARP inhibitor. Also called AZD2281, olaparib, and PARP inhibitor AZD2281.

Table 1. Record
IdentifierMLC-T-ONC-005057
FieldOncology and biomedicine
SynonymsAZD2281; olaparib; PARP inhibitor AZD2281
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005057",
  "term": "Lynparza",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat adults with certain types of prostate cancer, pancreatic cancer, breast cancer, or ovarian, fallopian tube, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. Lynparza blocks an enzyme involved in many cell functions, including the repair of DNA damage. Blocking this enzyme may help keep cancer cells from repairing their damaged DNA, causing them to die. Lynparza is a type of PARP inhibitor. Also called AZD2281, olaparib, and PARP inhibitor AZD2281.",
  "synonyms": [
    "AZD2281",
    "olaparib",
    "PARP inhibitor AZD2281"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/lynparza/"
}

Record 10,495 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.